Defibrotide Sodium - National Cancer Institute

Defibrotide Sodium - National Cancer Institute

Defibrotide Sodium

• 
• 
• 
• 
• 
• 
• 

listen (dee-FY-broh-tide SOH-dee-um)

This page contains brief information about defibrotide sodium and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)

Defitelio

FDA Approved

Yes

FDA Approval for Defibrotide Sodium

Use in Cancer

Defibrotide sodium is approved to treat:

• Hepatic veno-occlusive disease (also known as sinusoidal obstruction syndrome) in adults and children who also have kidney or lung problems after receiving a stem cell transplant.

More About Defibrotide Sodium

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

Clinical Trials Accepting Patients

Find Clinical Trials for Defibrotide Sodium - Check for trials from NCI's list of cancer clinical trials now accepting patients.

Important: The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.

• Posted: April 6, 2016
• Updated: April 6, 2016